Berchuck A - Search Results

1

Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms.

Davidson NR, Barnard ME, Hippen AA, Campbell A, Johnson CE, Way GP, Dalley BK, Berchuck A, Salas LA, Peres LC, Marks JR, Schildkraut JM, Greene CS, Doherty JA. Davidson NR, et al. Among authors: berchuck a. bioRxiv [Preprint]. 2023 Dec 2:2023.11.01.565179. doi: 10.1101/2023.11.01.565179. bioRxiv. 2023. PMID: 37961178 Free PMC article. Updated. Preprint.

2

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

3

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: berchuck a. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

4

Overexpression and mutation of p53 in epithelial ovarian cancer.

Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A. Marks JR, et al. Among authors: berchuck a. Cancer Res. 1991 Jun 1;51(11):2979-84. Cancer Res. 1991. PMID: 2032235

5

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR. Elbendary A, et al. Among authors: berchuck a. Cell Growth Differ. 1994 Dec;5(12):1301-7. Cell Growth Differ. 1994. PMID: 7696178

6

Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer.

Schildkraut JM, Collins NK, Dent GA, Tucker JA, Barrett JC, Berchuck A, Boyd J. Schildkraut JM, et al. Among authors: berchuck a. Am J Obstet Gynecol. 1995 Mar;172(3):908-13. doi: 10.1016/0002-9378(95)90020-9. Am J Obstet Gynecol. 1995. PMID: 7892884

7

Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.

Liu FS, Kohler MF, Marks JR, Bast RC Jr, Boyd J, Berchuck A. Liu FS, et al. Among authors: berchuck a. Obstet Gynecol. 1994 Jan;83(1):118-24. Obstet Gynecol. 1994. PMID: 8272291

8

The p53 tumor suppressor gene frequently is altered in gynecologic cancers.

Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RC Jr. Berchuck A, et al. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):246-52. doi: 10.1016/s0002-9378(94)70414-7. Am J Obstet Gynecol. 1994. PMID: 8296829 Review.

9

Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells.

Lidor YJ, Xu FJ, Martínez-Maza O, Olt GJ, Marks JR, Berchuck A, Ramakrishnan S, Berek JS, Bast RC Jr. Lidor YJ, et al. Among authors: berchuck a. Exp Cell Res. 1993 Aug;207(2):332-9. doi: 10.1006/excr.1993.1200. Exp Cell Res. 1993. PMID: 8344385

10

Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.

Kohler MF, Marks JR, Wiseman RW, Jacobs IJ, Davidoff AM, Clarke-Pearson DL, Soper JT, Bast RC Jr, Berchuck A. Kohler MF, et al. Among authors: berchuck a. J Natl Cancer Inst. 1993 Sep 15;85(18):1513-9. doi: 10.1093/jnci/85.18.1513. J Natl Cancer Inst. 1993. PMID: 8360934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

632 results

Search Page